...
首页> 外文期刊>Renal failure. >Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity
【24h】

Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity

机译:西罗莫司对他克莫司引起的肝毒性肾移植受者的抢救治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Calcineurin inhibitors at elevated serum concentrations frequently cause mild elevation of the liver chemistries. Although rare, severe hepatotoxicity is their serious complication. A 54-year-old man with end-stage renal disease due to chronic glomerulonephritis without biopsy received a renal allograft from the deceased donor. Eleven days after transplantation severe liver injury (AST up to 421IU/L, ALT 1242IU/L, and GGT 212IU/L) with the serum bilirubin within the normal range was recorded. Tacrolimus trough level was 5.5ng/mL. Liver ultrasound and color-Doppler of the portal system were normal. Liver failure completely resolved after withdrawal of the calcineurin inhibitor and switch to sirolimus. After 9 months of follow-up our patient has excellent graft and liver function. Awareness of the possible association of tacrolimus use with hepatotoxicity is important to timely discontinuation of the causative agent, and to introduce sirolimus as the rescue therapy.
机译:血清浓度升高的钙调神经磷酸酶抑制剂经常引起肝脏化学物质轻度升高。尽管罕见,但严重的肝毒性是其严重的并发症。一名54岁因慢性肾小球肾炎而未进行活检而患有终末期肾脏疾病的男子接受了已故供体的肾脏同种异体移植。移植后第11天记录了血清胆红素在正常范围内的严重肝损伤(AST高达421IU / L,ALT 1242IU / L和GGT 212IU / L)。他克莫司谷水平为5.5ng / mL。门静脉系统的肝脏超声和彩色多普勒检查正常。停用钙调神经磷酸酶抑制剂并改用西罗莫司后,肝功能衰竭完全解决。经过9个月的随访,我们的患者具有出色的移植物和肝功能。意识到使用他克莫司可能与肝毒性有关,这对于及时停用病原体和引入西罗莫司作为抢救疗法非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号